Study guide
Preoperative assessment and medicines
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Preoperative assessment and medicines
Key Takeaways Explain This Topic AI
For major procedures, SGLT2 inhibitors are generally withheld for two preceding days and the procedure day.
Australian 2025 GLP1/GIP guidance recommends continuation with a 24-hour clear-fluid diet before standard fasting.
Anticoagulant interruption and bridging depend on procedure and thrombotic risk.
Last updated: October 2026
Preoperative Risk Stratification & Postoperative Surgical Complications
Perioperative medicine bridges preoperative risk stratification and active postoperative vigilance, aiming to minimize surgical morbidity and accelerate recovery. Structured multidisciplinary evaluation in the preoperative clinic, adherence to pharmacology withholding guidelines, and systematic evaluation of postoperative complications are fundamental components of patient safety in Australian surgical practice.
Preoperative Risk Stratification & Functional Capacity
Preoperative assessment seeks to detect undiagnosed chronic illnesses, optimize pre-existing medical conditions, quantify perioperative cardiopulmonary risk, and plan post-surgical monitoring (ward vs high-dependency or intensive care unit).
Functional Capacity: Metabolic Equivalents (METs)
Cardiopulmonary exercise tolerance is an exceptionally strong predictor of postoperative outcome. Functional capacity is quantified in Metabolic Equivalents of Task (METs) , where 1 MET 1\text{ MET} 1 MET represents the basal oxygen consumption of an adult at rest ( 3.5 mL O 2 /kg/min 3.5\text{ mL }O_2\text{/kg/min} 3.5 mL O 2 /kg/min ):
≥ 4 METs \ge 4\text{ METs} ≥ 4 METs (Adequate Functional Capacity) : The patient can climb two flights of stairs without stopping, walk up a moderate hill, carry a bag of groceries ( > 10 kg > 10\text{ kg} > 10 kg ), or perform heavy household work. Patients with ≥ 4 METs \ge 4\text{ METs} ≥ 4 METs have low rates of major adverse cardiac events, and can generally proceed to elective surgery without advanced cardiac stress imaging.
< 4 METs < 4\text{ METs} < 4 METs (Poor Functional Capacity) : The patient cannot walk four blocks or climb two flights of stairs without stopping. Poor functional capacity indicates diminished cardiopulmonary reserve and mandates formal cardiovascular risk stratification.
The Revised Cardiac Risk Index (RCRI / Lee's Criteria)
The RCRI is the standard validated tool for predicting major adverse cardiac events (MACE: myocardial infarction, pulmonary oedema, complete heart block, or cardiac arrest) following non-cardiac surgery. It incorporates six independent clinical variables (each assigned 1 point):
High-risk surgical procedure : Intraperitoneal, intrathoracic, or suprainguinal vascular surgery.
History of ischemic heart disease : Previous myocardial infarction, positive stress test, active angina, or pathological Q waves on ECG.
History of congestive heart failure : Current or prior signs, elevated BNP, or history of pulmonary oedema.
History of cerebrovascular disease : Prior stroke or transient ischemic attack.
Preoperative insulin therapy for diabetes mellitus .
Preoperative renal impairment : Serum creatinine > 177 μ mol/L > 177\text{ }\mu\text{mol/L} > 177 μ mol/L ( > 2.0 mg/dL > 2.0\text{ mg/dL} > 2.0 mg/dL ).
MACE Risk Stratification :
Class I ( 0 points 0\text{ points} 0 points ): 0.4 % 0.4\% 0.4% cardiac risk.
Class II ( 1 point 1\text{ point} 1 point ): 0.9 % 0.9\% 0.9% cardiac risk.
Class III ( 2 points 2\text{ points} 2 points ): 6.6 % 6.6\% 6.6% cardiac risk.
Class IV ( ≥ 3 points \ge 3\text{ points} ≥ 3 points ): > 11 % > 11\% > 11% cardiac risk; requires multidisciplinary anaesthetic and cardiology review, optimization, and post-op telemetry/ICU placement.
Pulmonary Risk & Smoking Cessation
Risk factors for postoperative pulmonary complications (atelectasis, pneumonia, prolonged mechanical ventilation) include advanced age ( > 65 > 65 > 65 years), COPD, obstructive sleep apnoea (STOP-Bang score), and current smoking. Smoking cessation ≥ 4 to 8 weeks \ge 4\text{ to }8\text{ weeks} ≥ 4 to 8 weeks prior to surgery improves tracheobronchial ciliary clearance and reduces sputum volume; quitting even 24 to 48 hours 24\text{ to }48\text{ hours} 24 to 48 hours before surgery significantly eliminates carbon monoxide and restores tissue oxygen delivery.
Perioperative Medication Management Guidelines
Managing chronic medications requires balancing the risks of intraoperative physiological instability against the rebound exacerbation of chronic diseases.
Antihypertensives & Cardiovascular Drugs
ACE inhibitors/ARBs: The anaesthetic plan depends on indication, haemodynamics and procedure. Omitting a dose may reduce hypotension when used for hypertension; HFrEF and other indications require individual assessment rather than a universal stop rule.
Beta-Blockers (e.g., metoprolol, atenolol, bisoprolol) : Continue without interruption throughout the perioperative period. Abrupt cessation provokes rebound sympathetic hyperactivity, tachycardia, severe hypertension, and acute myocardial ischaemia. However, acute initiation of high-dose beta-blockade on the day of surgery is dangerous and increases perioperative stroke and mortality.
Statins & Calcium Channel Blockers : Continue throughout the perioperative period.
Diabetes Medications
SGLT2 medicines: Australian guidance for major surgery or procedures involving bowel preparation generally omits the drug for two days before and on the procedure day (three days total). Minor procedures differ. Check ketones in an unwell or fasting patient, even with normal glucose, and restart only when clinically safe and eating normally.
Metformin: Manage according to fasting, kidney function and contrast-associated AKI risk. Every contrast study does not require an automatic 48-hour interruption; use the radiology/diabetes protocol and reassess renal function where indicated.
Sulfonylureas (e.g., gliclazide) : Withhold on the morning of surgery while fasting to avoid intraoperative hypoglycaemia.
GLP1/GIP medicines: The 2025 Australian multisociety recommendation is to continue therapy, use a 24-hour clear-fluid diet before the procedure followed by standard fasting, and assess aspiration mitigation when this has not occurred. Coordinate with anaesthesia and local protocols; a routine weekly-dose seven-day hold imported from earlier overseas guidance is not the current Australian default.
Insulin : Reduce the basal insulin dose by 20 % to 30 % 20\%\text{ to }30\% 20% to 30% on the evening before or morning of surgery; withhold short-acting bolus insulin while fasting. For major surgeries or prolonged fasting, transition to a Variable Rate Intravenous Insulin Infusion (VRIII) with 5 % 5\% 5% dextrose and potassium.
Anticoagulants & Antiplatelets
Aspirin : Continue for secondary prevention (e.g., prior coronary stents, ischemic stroke) in most operations; withhold 7 days prior only for high-bleeding-risk operations (intracranial, spinal, or posterior eye surgery).
Antiplatelets: Balance bleeding with stent thrombosis risk and consult cardiology for recent PCI. If interruption is appropriate, the interval differs between ticagrelor, clopidogrel and prasugrel; never substitute one blanket five-day rule.
Direct Oral Anticoagulants (DOACs: apixaban, rivaroxaban, dabigatran) : Withhold 24 to 48 hours prior for low/moderate bleeding risk procedures, and 48 to 72 hours (or longer if renal clearance is impaired) for high bleeding risk procedures. Routine heparin bridging is not indicated for DOACs.
Warfarin : Withhold 5 days prior, targeting an INR < 1.5 < 1.5 < 1.5 . Bridging with therapeutic low-molecular-weight heparin (LMWH) is reserved strictly for high-thromboembolic-risk patients (mechanical mitral valves, recent stroke < 3 months < 3\text{ months} < 3 months , recent VTE < 3 months < 3\text{ months} < 3 months ).
Corticosteroids
Steroid exposure can suppress adrenal reserve, but the risk depends on dose, duration, recency and the patient. Continue necessary baseline treatment and plan supplemental cover according to surgical stress and the relevant endocrine/anaesthetic pathway. Every person who took steroids in the preceding year does not automatically need the same high-dose regimen.
Primary references (checked 7 October 2026): Australian 2025 GLP1/GIP perioperative recommendations .